The JAK inhibitor tofacitinib regulates synovitis through inhibition of interferon-γ and interleukin-17 production by human CD4+ T cells-Reference-Cited by-同舟云学术

The JAK inhibitor tofacitinib regulates synovitis through inhibition of interferon-γ and interleukin-17 production by human CD4+ T cells

Published:2012-05-25 Issue:6 Volume:64 Page:1790-1798
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis & Rheumatism

Author:

Maeshima Keisuke,Yamaoka Kunihiro,Kubo Satoshi,Nakano Kazuhisa,Iwata Shigeru,Saito Kazuyoshi,Ohishi Masanobu,Miyahara Hisaaki,Tanaka Shinya,Ishii Koji,Yoshimatsu Hironobu,Tanaka Yoshiya

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/art.34329/fullpdf

Reference28 articles.

1. Tyrosine kinases as targets in rheumatoid arthritis;Tristano;Int Immunopharmacol,2009

2. Tyrosine kinases as targets for the treatment of rheumatoid arthritis;D'Aura Swanson;Nat Rev Rheumatol,2009

3. Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development;Russell;Science,1995

4. Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID);Macchi;Nature,1995

5. Cartilage preservation by inhibition of Janus kinase 3 in two rodent models of rheumatoid arthritis;Milici;Arthritis Res Ther,2008

Cited by 193 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncostatin M-driven macrophage-fibroblast circuits as a drug target in autoimmune arthritis;Inflammation and Regeneration;2024-07-31

2. JAK Inhibitors in Rheumatoid Arthritis: Immunomodulatory Properties and Clinical Efficacy;International Journal of Molecular Sciences;2024-07-30

3. A Review of Myositis-Associated Interstitial Lung Disease;Journal of Clinical Medicine;2024-07-11

4. Harnessing immunity: Immunomodulatory therapies in COVID-19;World Journal of Virology;2024-06-25

5. The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1;New England Journal of Medicine;2024-05-30